OBR Jobs
Clovis Oncology, Inc.
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis intends to target development programs at specific subsets
of cancer populations, and will simultaneously develop diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. The Company is currently developing CO-101, which is in a pivotal study for the treatment of pancreatic cancer and CO-1686, an epidermal growth factor receptor (EGFR) mutant-selective inhibitor (EMSI) which is currently in pre-clinical development for non-small cell lung cancer (NSCLC) patients who express the T790M mutation. The Company is headquartered in Boulder, Colorado, and has additional offices in San Francisco and Cambridge, England.
View Job Listing »